News
-
-
-
PRESS RELEASE
Georgiamune and Menarini Group Enter Exclusive Global License and Collaboration Agreement for GIM-621, a First-in-Class Oral Immuno-Oncology Agent
Georgiamune and Menarini Group enter exclusive global license and collaboration agreement for GIM-621, a first-in-class oral immuno-oncology agent -
-
-
-
-
-
PRESS RELEASE
Menarini Group and NewAmsterdam Pharma Receive European Commission Approval for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)
Menarini Group and NewAmsterdam Pharma receive European Commission approval for Ubeslo and Evlarco, marking a milestone for cardiovascular disease treatment with LDL-C reduction therapies -
